Agenus | AGEN - Текущие активы





Текущие активы Изменить Дата
AbbVie USD 37.48B 3.81B 2026-09
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Celldex Therapeutics USD 724.93M 265.71M 2026-06
CSL USD 11.85B 1000K 2025-12
Eli Lilly USD 65.26B 591M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Glaxosmithkline GBP 17.9B 134M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 56.35B 3.42B 2026-09
Jiangsu Hengrui CNY 54.55B 4.95B 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck EUR 13.77B 393M 2026-06
Merck USD 36.68B 1.66B 2026-06
Northwest Biotherapeutics USD 6.2M 996K 2026-03
Novartis USD 28.75B 1.4B 2026-09
Novavax USD 771.1M 79.72M 2026-06
Pfizer USD 45.01B 3.65B 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 574.78M 52.6M 2026-06